Our study confirmed that intraperitoneal injection of the IL‐2:IL‐2 Ab complex after stroke increased the amount of Tregs on the 14th day after stroke and reduced neuronal death and myelin loss in the brain tissue on day 21 after stroke. This evidence concerns the gene IL2 and stroke disorder.